Performance highlights
→ Adjusted pre-tax profit up 8.2%
→ Over £90m invested in capital projects to drive future growth
→ Proposed special capital return of 100p per share
Sales value
£1,081.7m
Adjusted pre-tax profit
+8.2%
Free cash flow
£117.5m
Sales by market sector (£m)
£1,081.7m
Group sales
■ Personal Care
■ Life Sciences
■ Performance Technologies
■ Industrial Chemicals
Group
£377.3m
£231.3m
£345.8m
£118.3m
£1,081.7m
“
We are a strong cash generator with a disciplined approach to capital spend, investing in technology and capacity to meet customer demand, whilst also returning cash to shareholders."
Jez Maiden
Group Finance Director